Literature DB >> 20566795

Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver.

Irene Cruite1, Michael Schroeder, Elmar M Merkle, Claude B Sirlin.   

Abstract

OBJECTIVE: The purpose of this article is to review the use of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (gadoxetate disodium [Gd-EOB-DTPA]) in the cirrhotic liver and illustrate the imaging appearance of lesions commonly encountered in the cirrhotic liver.
CONCLUSION: Gd-EOB-DTPA shows promise as a problem-solving tool in the cirrhotic liver because it provides additional information that may be helpful in lesion detection and characterization. Further research is needed to optimize Gd-EOB-DTPA imaging protocols in cirrhosis and develop diagnostic criteria for liver lesions in the cirrhotic liver.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20566795     DOI: 10.2214/AJR.10.4538

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  57 in total

Review 1.  Solid liver masses: approach to management from the standpoint of a radiologist.

Authors:  Robert Garrett
Journal:  Curr Gastroenterol Rep       Date:  2013-12

2.  Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.

Authors:  Megumi Matsuda; Takaharu Tsuda; Shinji Yoshioka; Shigetoshi Murata; Hiroaki Tanaka; Masashi Hirooka; Yoichi Hiasa; Teruhito Mochizuki
Journal:  Jpn J Radiol       Date:  2014-05-24       Impact factor: 2.374

Review 3.  Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review.

Authors:  Paola Erra; Marta Puglia; Alfonso Ragozzino; Simone Maurea; Raffaele Liuzzi; Giuseppe Sabino; Luigi Barbuto; Alberto Cuocolo; Massimo Imbriaco
Journal:  Radiol Med       Date:  2015-04-22       Impact factor: 3.469

4.  Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients.

Authors:  Stephen R Bowen; Jatinder Saini; Tobias R Chapman; Robert S Miyaoka; Paul E Kinahan; George A Sandison; Tony Wong; Hubert J Vesselle; Matthew J Nyflot; Smith Apisarnthanarax
Journal:  Radiother Oncol       Date:  2015-04-28       Impact factor: 6.280

Review 5.  Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.

Authors:  Anum Aslam; Amita Kamath; Bradley Spieler; Mark Maschiocchi; Carl F Sabottke; Victoria Chernyak; Sara C Lewis
Journal:  Abdom Radiol (NY)       Date:  2021-04-15

6.  Time to update radiological criteria for non-invasive diagnosis of hepatocellular carcinoma.

Authors:  Sanjay Saini; Daniel S Pratt
Journal:  Hepatol Int       Date:  2014-11-02       Impact factor: 6.047

Review 7.  Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.

Authors:  Francesco Agnello; Marco Dioguardi Burgio; Dario Picone; Federica Vernuccio; Giuseppe Cabibbo; Lydia Giannitrapani; Adele Taibbi; Antonino Agrusa; Tommaso Vincenzo Bartolotta; Massimo Galia; Roberto Lagalla; Massimo Midiri; Giuseppe Brancatelli
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 8.  Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.

Authors:  Christopher H Crane; Eugene J Koay
Journal:  Cancer       Date:  2016-03-07       Impact factor: 6.860

Review 9.  MRI of diffuse liver disease: characteristics of acute and chronic diseases.

Authors:  Surya Chundru; Bobby Kalb; Hina Arif-Tiwari; Puneet Sharma; James Costello; Diego R Martin
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

10.  Liver perfusion in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): comparison of enhancement in Gd-BT-DO3A and Gd-EOB-DTPA in normal liver parenchyma.

Authors:  Hanke J Schalkx; Marijn van Stralen; Kenneth Coenegrachts; Maurice A A J van den Bosch; Charlotte S van Kessel; Richard van Hillegersberg; Karel J van Erpecum; Helena M Verkooijen; Josien P W Pluim; Wouter B Veldhuis; Maarten S van Leeuwen
Journal:  Eur Radiol       Date:  2014-07-05       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.